Skip to content
Boost Up Blog – Lifestyle
Author:
Kuros Biosciences AG
Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability
August 13, 2026
Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich
June 17, 2026
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth
May 7, 2026
Annual General Meeting of Kuros Biosciences approves all resolutions
April 15, 2026
Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026
April 14, 2026
Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025
March 10, 2026